Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care

Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care This retrospective observational analysis of health claims data compares the safety, effectiveness, and cost of biosimilar filgrastim and filgrastim. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care

Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/early-adoption-of-biosimilar-growth-factors-in-supportive-cancer-care-xc2HOySUY7

References (4)

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2018.5090
Publisher site
See Article on Publisher Site

Abstract

This retrospective observational analysis of health claims data compares the safety, effectiveness, and cost of biosimilar filgrastim and filgrastim.

Journal

JAMA Oncology – American Medical Association

Published: Dec 1, 2018

There are no references for this article.